alternative to bpc 157 BPC-157: Why Women Are Asking About It Inside the High-Stakes FDA Peptides

Proposed Mechanism BPC-157 appears to work through multiple pathways: Maintaining vesicular integrity (affecting VMATs and dopamine transporters) Possibly occupying its own vesicular storage sites Competing for dopamine receptor binding Functionally substituting when dopaminergic neurons are lost This last property, essentially filling in for missing dopamine function, would explain why the peptide counteracts both receptor agonists (apomorphine) and antagonists (haloperidol, fluphenazine, clozapine, sulpiride) with equal effectiveness

Improper use may also lead to more severe side effects

Pain Relief: Used off-label for certain chronic pain conditions due to its central nervous system effects

Arunim, Sarita, Mishra R, Bajpai S (2024) Development and characterization of carbopol-based hydrogel as diabetic wound dressing materials